SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640455-17-000010
Filing Date
2017-03-10
Accepted
2017-03-10 12:53:36
Documents
16
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jnce1231201610-k.htm 10-K 2256968
2 EXHIBIT 10.15 exhibit1015.htm EX-10.15 13160
3 EXHIBIT 23.1 exhibit231.htm EX-23.1 2874
4 EXHIBIT 31.1 exhibit311.htm EX-31.1 10368
5 EXHIBIT 31.2 exhibit312.htm EX-31.2 10365
6 EXHIBIT 32.1 exhibit321.htm EX-32.1 7884
7 g72672a02.jpg GRAPHIC 63279
8 g379686a01.jpg GRAPHIC 98739
9 g475797a01.jpg GRAPHIC 82029
10 g600598a01.jpg GRAPHIC 93362
11 g639644a01.jpg GRAPHIC 81322
12 g753014a01.jpg GRAPHIC 45415
13 g852019a01.jpg GRAPHIC 58963
14 g884698a01.jpg GRAPHIC 75338
15 g1026852a01.jpg GRAPHIC 87531
16 g1044131a01.jpg GRAPHIC 35512
  Complete submission text file 0001640455-17-000010.txt   3297595
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37998 | Film No.: 17681146
SIC: 2836 Biological Products, (No Diagnostic Substances)